By
Banjot Kaur
Published: July 5, 2024, 6:57 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Pediatrics,
Access,
Advocacy
New Delhi: In a big victory for TB activism and children suffering from TB in India, the country’s patent office rejected Johnson & Johnson’s (J&J) patent application for the paediatric formulation of Bedaquiline on Friday, July 5.
Read More →
By
Banjot Kaur
Published: Oct. 1, 2023, 10:02 p.m.·
Tags:
Treatment,
Access,
Advocacy
New Delhi, 01/Oct/2023: In an unusual repetition of sorts, the Union health ministry issued a press release on Sunday, October 1, denying any shortages of essential medicines for drug-resistant TB patients. It was only on September 26 that the ministry issued an almost similar statement.
Read More →
By
Banjot Kaur
Published: Sept. 29, 2019, 7:07 p.m.·
Tags:
TB epidemiology
The number of HIV-infected people who go on to develop TB is increasing in India, according to the India TB Report 2019, which was released by the government on September 25, 2019.
Read More →